Olympus Medical Corp. instituted a class I recall of its UHI-4 high flow insufflation device due to reports that the device may over-inflate and potentially create embolisms. The recall affects more ...
Phoenix, AZ, (May 18, 2023) - Findings from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD) were presented today as late-breaking clinical research at the Society for ...
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® ...
We see the high-flow devices and consumables, which are marketed under the Optiflow label, as having the most potential reach, as growing clinical evidence is promoting use of this therapy outside of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results